𝔖 Bobbio Scriptorium
✦   LIBER   ✦

123I-iodobenzoylglucosamines: Glucose analogues for heart imaging

✍ Scribed by T. Lutz; H. Dougan; T. Rihela; C. V. Vo; D. M. Lyster

Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
842 KB
Volume
33
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The ortho‐, meta‐ and para‐[^123^I]‐2‐deoxy‐2‐N‐(iodobenzoyl)‐D‐glucosamine (BGA) derivatives were investigated to determine the effect of iodine position and lipophilicity on tissue distribution. There was no correlation between tissue uptake and lipophilicity. Maximum uptake was observed for o‐BGA displaying a heart:blood ratio of 36.0 at 18 hours post injection. Yeast hexokinase phosphorylation studies in vitro and an in vivo insulin experiment were carried out on o‐BGA. No phosphorylation was detected, but the insulin study indicated that o‐BGA uses the glucose transporter. o‐BGA showed maximum tissue uptake in mice at an optimal specific activity of 0.004mg/μCi. Mouse biodistribution studies of o‐[^123^I]‐iodobenzamide(o‐^123^IBA) indicated that the glucose moiety of o‐BGA may be involved in the heart accumulation process in mice. Heart tissue extraction studies showed unmetabolized o‐[^123^I]BGA, recorded at 14 hours post injection, showed significant heart uptake.

📜 SIMILAR VOLUMES

Synthesis and biological evaluation of 1
Synthesis and biological evaluation of 125I/123I-labelled analogues of citalopram and escitalopram as potential radioligands for imaging of the serotonin transporter
✍ Jacob Madsen; Betina Elfving; Vibe G. Frokjaer; Birgitte R. Kornum; Gerda Thomse 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 199 KB

## Abstract Two novel radioligands for the serotonin transporter (SERT), [^125^I]{3‐[5‐iodo‐1‐[4‐fluorophenyl)‐1,3‐dihydroisobenzofuran‐1‐yl]‐propyl}‐dimethylamine ([^125^I]‐2) and __S__‐[^125^I]{3‐[5‐iodo‐1‐(4‐fluorophenyl)‐1,3‐dihydroisobenzofuran‐1‐yl]‐propyl}‐dimethylamine ([^125^I]‐(__S__)‐2)

[123I]-FP/CIT SPECT imaging for distingu
[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease
✍ Mordechai Lorberboym; Therese A. Treves; Eldad Melamed; Yair Lampl; Mark Hellman 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

## Abstract Parkinsonism in patients taking neuroleptic medications might be induced by dopamine receptor blockade alone or by dopamine blockade with nigrostriatal dysfunction. The differentiation between Parkinson's disease (PD) and drug‐induced parkinsonism (DIP) is difficult to assess on clinica

Synthesis of (R, R)123I-QNB, A spect ima
Synthesis of (R, R)123I-QNB, A spect imaging agent for cerebral muscarinic acetylcholine receptors in vivo
✍ J. Owens; T. Murray; J. McCulloch; D. Wyper 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 737 KB

## Abstract The high‐affinity muscarinic receptor antagonist (R,R) I‐QNB^(1)^ [(R)‐(‐)‐1‐Azabicyclo [2.2.2]oct‐3‐yl‐ (R) ‐ (+) ‐ α‐hydroxy‐α‐(4‐[^127^I]iodophenyl)‐α‐phenyl Acetate (6a)] has been labeled with iodine‐123 to give a suitable ligand for SPECT (Single photon emission computed tomography